Keep Us Strong WikiLeaks logo

Currently released so far... 97115 / 251,287

Articles

Browse latest releases

Browse by creation date

Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z

Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ETRD EAGR ETTC EAID ECON EFIN ECIN EINV ELAB EAIR ENRG EPET EWWT ECPS EIND EMIN ELTN EC ETMIN EUC EZ ET ELECTIONS ENVR EU EUN EG EINT ER ECONOMICS ES EMS ENIV EEB EN ECE ECOSOC EK ENVIRONMENT EFIS EI EWT ENGRD ECPSN EXIM EIAD ERIN ECPC EDEV ENGY ECTRD EPA ESTH ECCT EINVECON ENGR ERTD EUR EAP EWWC ELTD EL EXIMOPIC EXTERNAL ETRDEC ESCAP ECO EGAD ELNT ECONOMIC ENV ETRN EIAR EUMEM ENRGPARMOTRASENVKGHGPGOVECONTSPLEAID EREL ECOM ECONETRDEAGRJA ETCC ETRG ECONOMY EMED ETR ENERG EITC EFINOECD EURM EENG ERA EXPORT ENRD ECONEINVETRDEFINELABETRDKTDBPGOVOPIC EGEN EBRD EVIN ETRAD ECOWAS EFTA ECONETRDBESPAR EGOVSY EPIN EID ECONENRG EDRC ESENV ETT EB ENER ELTNSNAR ECHEVARRIA ETRC EPIT EDUC ESA EFI ENRGY ESCI EE EAIDXMXAXBXFFR EETC ECIP EIAID EIVN EBEXP ESTN EING EGOV ETRA EPETEIND ELAN ETRDGK EAIDRW ETRDEINVECINPGOVCS EPEC ENVI ELN EAG EPCS EPRT EPTED ETRB EUM EAIDS EFIC EFINECONEAIDUNGAGM EAIDAR ESF EIDN ELAM EDU EV EAIDAF ECN EDA EXBS EINTECPS ENRGTRGYETRDBEXPBTIOSZ EPREL EAC EINVEFIN ETA EAGER EINDIR ECA ECLAC ELAP EITI EUCOM ECONEFINETRDPGOVEAGRPTERKTFNKCRMEAID EARG ELDIN EINVKSCA ENNP EFINECONCS EFINTS ECCP ETC EAIRASECCASCID EINN ETRP EAIDNI EFQ ECOQKPKO EGPHUM EBUD ECONEINVEFINPGOVIZ ENERGY ELB EINDETRD EMI ECONEFIN EIB EURN ETRDEINVTINTCS EIN EFIM ETIO ELAINE EMN EATO EWTR EIPR EINVETC ETTD ETDR EIQ ECONCS EPPD ENRGIZ EISL ESPINOSA ELEC EAIG ESLCO EUREM ENTG ERD EINVECONSENVCSJA EEPET EUNCH ECINECONCS ETRO ETRDECONWTOCS ECUN EFND EPECO EAIRECONRP ERGR ETRDPGOV ECPN ENRGMO EPWR EET EAIS EAGRE EDUARDO EAGRRP EAIDPHUMPRELUG EICN ECONQH EVN EGHG ELBR EINF EAIDHO EENV ETEX ERNG ED
KMDR KPAO KPKO KJUS KCRM KGHG KFRD KWMN KDEM KTFN KHIV KGIC KIDE KSCA KNNP KHUM KIPR KSUM KISL KIRF KCOR KRCM KPAL KWBG KN KS KOMC KSEP KFLU KPWR KTIA KSEO KMPI KHLS KICC KSTH KMCA KVPR KPRM KE KU KZ KFLO KSAF KTIP KTEX KBCT KOCI KOLY KOR KAWC KACT KUNR KTDB KSTC KLIG KSKN KNN KCFE KCIP KGHA KHDP KPOW KUNC KDRL KV KPREL KCRS KPOL KRVC KRIM KGIT KWIR KT KIRC KOMO KRFD KUWAIT KG KFIN KSCI KTFIN KFTN KGOV KPRV KSAC KGIV KCRIM KPIR KSOC KBIO KW KGLB KMWN KPO KFSC KSEAO KSTCPL KSI KPRP KREC KFPC KUNH KCSA KMRS KNDP KR KICCPUR KPPAO KCSY KTBT KCIS KNEP KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KNNB KGCC KINR KPOP KMFO KENV KNAR KVIR KDRG KDMR KFCE KNAO KDEN KGCN KICA KIMMITT KMCC KLFU KMSG KSEC KUM KCUL KMNP KSMT KCOM KOMCSG KSPR KPMI KRAD KIND KCRP KAUST KWAWC KTER KCHG KRDP KPAS KITA KTSC KPAOPREL KWGB KIRP KJUST KMIG KLAB KTFR KSEI KSTT KAPO KSTS KLSO KWNN KPOA KHSA KNPP KPAONZ KBTS KWWW KY KJRE KPAOKMDRKE KCRCM KSCS KWMNCI KESO KWUN KPLS KIIP KEDEM KPAOY KRIF KGICKS KREF KTRD KFRDSOCIRO KTAO KJU KWMNPHUMPRELKPAOZW KEN KO KNEI KEMR KKIV KEAI KWAC KRCIM KWCI KFIU KWIC KCORR KOMS KNNO KPAI KBWG KTTB KTBD KTIALG KILS KFEM KTDM KESS KNUC KPA KOMCCO KCEM KRCS KWBGSY KNPPIS KNNPMNUC KWN KERG KLTN KALM KCCP KSUMPHUM KREL KGH KLIP KTLA KAWK KWMM KVRP KVRC KAID KSLG KDEMK KX KIF KNPR KCFC KFTFN KTFM KPDD KCERS KMOC KDEMAF KMEPI KEMS KDRM KEPREL KBTR KEDU KNP KIRL KNNR KMPT KISLPINR KTPN KA KJUSTH KPIN KDEV KTDD KAKA KFRP KWNM KTSD KINL KJUSKUNR KWWMN KECF KWBC KPRO KVBL KOM KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KEDM KFLD KLPM KRGY KNNF KICR KIFR KM KWMNCS KAWS KLAP KPAK KDDG KCGC KID KNSD KMPF KPFO KDP KCMR KRMS KNPT KNNNP KTIAPARM KDTB KNUP KPGOV KNAP KNNC KUK KSRE KREISLER KIVP KQ KTIAEUN KPALAOIS KRM KISLAO KWM KFLOA
PHUM PINR PTER PGOV PREL PREF PL PM PHSA PE PARM PINS PK PUNE PO PALESTINIAN PU PBTS PROP PTBS POL POLI PA PGOVZI POLMIL POLITICAL PARTIES POLM PD POLITICS POLICY PAS PMIL PINT PNAT PV PKO PPOL PERSONS PING PBIO PH PETR PARMS PRES PCON PETERS PRELBR PT PLAB PP PAK PDEM PKPA PSOCI PF PLO PTERM PJUS PSOE PELOSI PROPERTY PGOVPREL PARP PRL PNIR PHUMKPAL PG PREZ PGIC PBOV PAO PKK PROV PHSAK PHUMPREL PROTECTION PGOVBL PSI PRELPK PGOVENRG PUM PRELKPKO PATTY PSOC PRIVATIZATION PRELSP PGOVEAIDUKNOSWGMHUCANLLHFRSPITNZ PMIG PREC PAIGH PROG PSHA PARK PETER POG PHUS PPREL PS PTERPREL PRELPGOV POV PKPO PGOVECON POUS PGOVPRELPHUMPREFSMIGELABEAIDKCRMKWMN PWBG PMAR PREM PAR PNR PRELPGOVEAIDECONEINVBEXPSCULOIIPBTIO PARMIR PGOVGM PHUH PARTM PN PRE PTE PY POLUN PPEL PDOV PGOVSOCI PIRF PGOVPM PBST PRELEVU PGOR PBTSRU PRM PRELKPAOIZ PGVO PERL PGOC PAGR PMIN PHUMR PVIP PPD PGV PRAM PINL PKPAL PTERE PGOF PINO PHAS PODC PRHUM PHUMA PREO PPA PEPFAR PGO PRGOV PAC PRESL PORG PKFK PEPR PRELP PREFA PNG PGOVPHUMKPAO PRELECON PINOCHET PFOR PGOVLO PHUMBA PRELC PREK PHUME PHJM POLINT PGOVPZ PGOVKCRM PGOVE PHALANAGE PARTY PECON PEACE PROCESS PLN PRELSW PAHO PEDRO PRELA PASS PPAO PGPV PNUM PCUL PGGV PSA PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PGIV PRFE POGOV PEL PBT PAMQ PINF PSEPC POSTS PHUMPGOV PVOV PHSAPREL PROLIFERATION PENA PRELTBIOBA PIN PRELL PGOVPTER PHAM PHYTRP PTEL PTERPGOV PHARM PROTESTS PRELAF PKBL PRELKPAO PKNP PARMP PHUML PFOV PERM PUOS PRELGOV PHUMPTER PARAGRAPH PERURENA PBTSEWWT PCI PETROL PINSO PINSCE PQL PEREZ PBS

Browse by classification

Community resources

courage is contagious

Viewing cable 08KYIV1056, UKRAINE CONTINUES DIALOGUE WITH PHARMACEUTICAL

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs

Understanding cables
Every cable message consists of three parts:
  • The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
  • The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
  • The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.
To understand the justification used for the classification of each cable, please use this WikiSource article as reference.

Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #08KYIV1056.
Reference ID Created Released Classification Origin
08KYIV1056 2008-06-02 07:52 2011-08-24 16:30 UNCLASSIFIED//FOR OFFICIAL USE ONLY Embassy Kyiv
VZCZCXYZ0000
RR RUEHWEB

DE RUEHKV #1056/01 1540752
ZNR UUUUU ZZH
R 020752Z JUN 08
FM AMEMBASSY KYIV
TO RUEHC/SECSTATE WASHDC 5713
INFO RUEAWJA/DEPT OF JUSTICE WASHDC
RUCPDOC/USDOC WASHDC
RUEHSF/AMEMBASSY SOFIA 0035
UNCLAS KYIV 001056 
 
SIPDIS 
SENSITIVE 
 
STATE FOR EUR/UMB AND EB/TPP/IPE 
STATE PLEASE PASS TO USTR FOR BURKHEAD/GROVES 
USDOC FOR 4231/ITA/OEENIS/NISD/CLUCYCK 
USDOC FOR CLDP 
SOFIA FOR MLAMBERTI 
 
E.O. 12958: DECL: N/A 
TAGS: ETRD KIPR ECON UP
SUBJECT: UKRAINE CONTINUES DIALOGUE WITH PHARMACEUTICAL 
INDUSTRY ON IPR ISSUES 
 
REFS: A) KYIV 456 
 
      B) KYIV 110 
      C) 2007 KYIV 2865 
      D) 2007 KYIV 1780 
      E) 2007 KYIV 1452 
 
Treat as Sensitive but Unclassified.  Not for Internet. 
 
1. (SBU) Summary: The GOU held a public roundtable on May 
28 to discuss IPR enforcement issues of importance to the 
pharmaceutical industry.  GOU reps said they were now 
implementing the data exclusivity provisions agreed to as 
part of Ukraine's accession to the WTO, but admitted that 
generic drugs were sometimes still able to improperly 
receive market approval.  There was some dispute over the 
role that executive branch agencies should be playing in 
regulating pharmaceutical approvals as opposed to the 
judiciary, but the GOU committed to do what it could to 
bolster enforcement.  End Summary. 
 
2. (U) EconOff attended a May 28 roundtable entitled "Legal 
Enforcement and Protection of Medicines," hosted by the 
State Department of Intellectual Property (SDIP), Ukraine's 
lead agency for intellectual property rights (IPR) issues. 
The roundtable brought together officials from SDIP, the 
Ministry of Health, and the State Pharmacological Center -- 
responsible for registering new pharmaceutical drugs (i.e. 
granting market approval) -- with representatives of the 
pharmaceutical industry, mostly local patent lawyers 
employed by large international firms.  The event was a 
follow-up to a November 2007 meeting of the U.S.-Ukraine 
Enforcement Cooperation Group (ECG) that focused on similar 
issues (ref C). 
 
Enforcing WTO Rules... 
---------------------- 
 
3. (U) Volodymyr Dmytryshyn, SDIP Deputy Chairman, 
emphasized the importance of improving IPR enforcement in 
the pharmaceutical sector in order to both protect the 
rights of companies operating in Ukraine and to ensure that 
Ukrainians have access to safe, quality medicines. 
Dmytryshyn and Olga Baula, 1st Deputy Chairperson of the 
State Pharmacological Center, noted Ukraine's accession to 
the WTO on May 16 and said that the GOU was now enforcing 
the five-year data exclusivity provisions agreed to as part 
of WTO accession negotiations. 
 
4. (SBU) Baula said that the State Pharmacological Center 
was doing its best to make its drug registration system as 
transparent as possible, noting that new applications were 
now publicly available on the internet.  (Note: Poor access 
to applications had previously been a primary complaint of 
pharmaceutical companies.  End note.)  She added that the 
State Pharmacological Center was trying to develop a cadre 
of its own experts, recognizing that the current situation, 
with some of its staff working part-time in the private 
sector, created the potential for a conflict of interests. 
 
... But a Data Exclusivity Loophole Remains 
------------------------------------------- 
 
5. (U) Baula admitted, however, that a problem remained in 
the enforcement of the data exclusivity provisions.  She 
said that generic producers were occasionally beating the 
original manufacturer to the Ukrainian market with 
applications to register their drugs.  In such cases, said 
Baula, with no application from the innovative drug 
producer on file, the generic would be registered even 
though its clinical test data would presumably come from a 
third party, and the five-year data exclusivity period 
could not be enforced.  Michael Doubinsky, a well-respected 
patent attorney who often advises the GOU, noted that other 
countries, including Russia, had tackled such problems and 
argued that Ukraine needed to make systematic changes to 
ensure that a generic drug could not get registered by the 
State Pharmacological Center before the original. 
 
Patent Linkage Also Needs Strengthening 
--------------------------------------- 
 
6. (U) Doubinsky added that, despite the improvements made 
as part of WTO accession, there was still a gap between 
 
patent applications and pharmaceutical registration rules. 
Too often a generic drug was able to improperly receive 
market approval when the patent of the original producer 
was still valid, said Doubinsky.  Baula responded that the 
State Pharmacological Center was not responsible for 
verifying the validity of patents, a task that fell to SDIP 
and the courts, before registering a drug. 
 
Reliance on Courts? 
------------------- 
 
7. (U) Doubinsky argued that relying on court litigation 
was not an efficient strategy, as patent cases often lasted 
as long as three years, and companies were loath to file a 
case against the State Pharmacological Center for fear of 
upsetting the principal government regulator.  Iryna 
Vasylenko, Head of SDIP's Legal Division, noted that courts 
officially had up to 1,460 days to rule on a patent case 
and that some judges still lacked the necessary expertise. 
 
8. (SBU) One local patent attorney criticized the USG for 
pressuring GOU agencies to defend the IP rights of U.S. 
pharmaceutical companies; such companies, he said, should 
use the Ukrainian court system.  EconOff responded that, 
while the USG was calling on Ukraine to improve protection 
of IP rights, it was up to Ukraine to decide how best to do 
so.  EconOff recognized that courts should play an 
important, although not solitary, role. 
 
Comment: Signs of Progress 
-------------------------- 
 
9. (U) That the GOU is now initiating public discussions 
with industry to explore how to improve IPR enforcement 
testifies to Ukraine's real progress over the last few 
years.  Ukraine's system of granting market access to 
pharmaceutical drugs remains imperfect, but the GOU appears 
serious about improving it.  Dmytryshyn, for example, said 
in his closing statements that the GOU recognized "the gap" 
between patent approvals and pharmaceutical registration 
and would work to eliminate it. 
 
10. (SBU) Contrary to the criticism directed at the USG, 
Post has long recognized the critical role of the courts in 
bolstering IPR enforcement and has targeted much of its IPR 
technical assistance on training Ukrainian judges (refs A- 
B, D-E).  Unfortunately, however, defending IP rights in 
Ukrainian courts remains costly, lengthy, and risky, as 
many judges lack the expertise needed to properly 
adjudicate IPR cases, and as corruption in the courts is 
still widespread.  Post believes that the path to enhanced 
IPR enforcement lies in improving the performance of both 
the relevant GOU agencies and the courts. 
 
TAYLOR